SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2008-11-14
Filing Date Changed: 2008-11-14
Documents: 2
SEC Accession No.
0000812796-08-000037
Filing date: 2008-11-14
Accepted: 2008-11-14 16:00:49
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K pr8k3q10q2008.htm 22804 8K PRESS RELEASE FOR EARNINGS 3Q 2008
2 EX-99.1 pr3q3008.htm 24826 PRESS RELEASE 3Q 2008
0000812796-08-000037.txt 49355 Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 081191214
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200
 Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628